Excerpt:“…be a decision before the presidential election given the tight schedule, said Criss Wang, an analyst at SMARTKARMA. However, the process may not be over due to conflicting information over the global pharmaceutical supply chain excluding China, added…”
BN (Bloomberg News)via Bloomberg • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
BN (Bloomberg News)
